Patients with Acute Severe Ulcerative Colitis Treated with IV Cyclosporine Who Require Colectomy Within 3 Months of Discharge Have Lower Serum Cyclosporine Levels

Author:

Friedberg Scott1,Steinberg Joshua M.1,Klein Jeremy A.1,Choi Natalie K.1,Choi David1,Shabbir Zaheera1,Rodriguez Tina1,Traboulsi Cindy1,Pekow Joel1,Micic Dejan1,Cohen Russell D.1,Dalal Sushila R.1,Cohen Nathaniel A.1,Rubin David T.1

Affiliation:

1. IBD Center, Section of Gastroenterology University of Chicago Medicine

Abstract

Abstract Background: Cyclosporine (CYS) is a calcineurin inhibitor commonly used as induction therapy in steroid-refractory patients with acute severe ulcerative colitis (ASUC) during hospitalization. Aim: To identify the relationship between post-hospitalization CYS serum levels and adverse clinical outcomes. Methods: Electronic medical records of patients with established diagnosis of UC hospitalized for ASUC discharged on oral CYS following IV CYS induction between May 2013 to December 2017 were retrospectively analyzed. Results: Of thirty-nine patients, five patients underwent colectomy during initial hospitalization; thirty-four remaining patients were analyzed. Twenty patients experienced CYS-related adverse events (AEs); five patients were dose-reduced and three patients were discontinued. CYS dose-reduced or discontinued patients were significantly more likely to have undergone colectomy within three months (62.5% vs 11.5%, p=0.009). Fifteen (44%) total patients who underwent colectomy within one year post-hospitalization; eight (23.5%) patients underwent colectomy within three months. Logistic regression analysis adjusting for age, sex, weight, albumin, CRP and AEs demonstrated subtherapeutic serum CYS level (<200 ng/mL) was independently associated with increased risk of three-month colectomy (aHR 20.95, 95% CI 1.5-284, p=0.02). Adjusting the model for selective inclusion of AEs requiring dose adjustment or discontinuation, subtherapeutic CYS levels remained independently associated with three-month colectomy (aHR 14.9, 95% CI 1.12-198.9, p=0.02). No significant differences in CYS levels or clinical characteristics in patients who underwent one-year colectomy were observed. Conclusions: We demonstrate independent association of subtherapeutic serum CYS levels following conversion to oral therapy with an increased risk of three-month colectomy, but not with one-year colectomy.

Publisher

Research Square Platform LLC

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3